MGRX vs. CISS
MGRX (Mangoceuticals Inc. Common Stock) and CISS (C3is Inc.) are both stocks. MGRX operates in Health Information Services (Healthcare), while CISS operates in Marine Shipping (Industrials). Over the past year, MGRX returned -82.14% vs -99.56% for CISS. At a 0.08 correlation, their price movements are largely independent.
Performance
MGRX vs. CISS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MGRX achieves a -49.32% return, which is significantly higher than CISS's -93.14% return.
MGRX
- 1D
- -2.09%
- 1M
- 10.95%
- YTD
- -49.32%
- 6M
- -69.51%
- 1Y
- -82.14%
- 3Y*
- -72.48%
- 5Y*
- —
- 10Y*
- —
CISS
- 1D
- 0.45%
- 1M
- -36.49%
- YTD
- -93.14%
- 6M
- -99.11%
- 1Y
- -99.56%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
MGRX vs. CISS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
MGRX Mangoceuticals Inc. Common Stock | -49.32% | -69.42% | -41.74% | -85.27% |
CISS C3is Inc. | -93.14% | -97.31% | -98.92% | -85.68% |
Correlation
The correlation between MGRX and CISS is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (All Time) Calculated using the full available price history since Jun 23, 2023 | 0.08 |
Fundamentals
MGRX:
$3.78M
CISS:
$769.01K
MGRX:
-$1.96
CISS:
$3.08
MGRX:
12.95
CISS:
0.11
MGRX:
0.25
CISS:
0.01
MGRX:
$304.81K
CISS:
$37.66M
MGRX:
$250.39K
CISS:
$8.58M
MGRX:
-$18.03M
CISS:
$12.89M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MGRX vs. CISS — Risk / Return Rank
MGRX
CISS
MGRX vs. CISS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Mangoceuticals Inc. Common Stock (MGRX) and C3is Inc. (CISS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MGRX | CISS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.13 | ||
| Sortino ratioReturn per unit of downside risk | +2.47 | ||
| Omega ratioGain probability vs. loss probability | 0.99 | 0.59 | +0.39 |
| Calmar ratioReturn relative to maximum drawdown | -0.87 | -1.00 | +0.13 |
| Martin ratioReturn relative to average drawdown | -1.37 | -1.36 | -0.01 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| MGRX | CISS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.45 | -0.58 | +0.13 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.49 | -0.69 | +0.20 |
Drawdowns
MGRX vs. CISS - Drawdown Comparison
The maximum MGRX drawdown since its inception was -99.73%, roughly equal to the maximum CISS drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for MGRX and CISS.
Loading charts...
Drawdown Indicators
| MGRX | CISS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.73% | -100.00% | +0.27% |
Max Drawdown (1Y)Largest decline over 1 year | -94.09% | -99.63% | +5.54% |
Max Drawdown (3Y)Largest decline over 3 years | -99.43% | — | — |
Current DrawdownCurrent decline from peak | -99.38% | -100.00% | +0.62% |
Average DrawdownAverage peak-to-trough decline | -89.99% | -96.66% | +6.67% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 60.15% | 73.28% | -13.13% |
Volatility
MGRX vs. CISS - Volatility Comparison
Mangoceuticals Inc. Common Stock (MGRX) has a higher volatility of 46.15% compared to C3is Inc. (CISS) at 24.06%. This indicates that MGRX's price experiences larger fluctuations and is considered to be riskier than CISS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MGRX | CISS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 46.15% | 24.06% | +22.09% |
Volatility (6M)Calculated over the trailing 6-month period | 159.82% | 200.58% | -40.76% |
Volatility (1Y)Calculated over the trailing 1-year period | 183.82% | 172.38% | +11.44% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 164.09% | 144.02% | +20.07% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 164.09% | 144.02% | +20.07% |
Dividends
MGRX vs. CISS - Dividend Comparison
Neither MGRX nor CISS has paid dividends to shareholders.
Financials
MGRX vs. CISS - Financials Comparison
This section allows you to compare key financial metrics between Mangoceuticals Inc. Common Stock and C3is Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MGRX and CISS have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MGRX has higher volatility (46.15%) compared to CISS (24.06%). In terms of maximum drawdown, MGRX dropped -99.73% vs CISS's -100.00%.
MGRX currently has the higher Sharpe Ratio (-0.45 vs -0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MGRX and CISS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer